Gilead Sciences (GILD) Tops Q3 EPS by 94c
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $146.64 -2.88%
EPS Growth %: -14.2%
Financial Fact:
Product sales: 7.41B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -14.2%
Financial Fact:
Product sales: 7.41B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q3 EPS of $2.65, $0.94 better than the analyst estimate of $1.71. Revenue for the quarter came in at $7.4 billion versus the consensus estimate of $6.18 billion.
GUIDANCE:
Gilead Sciences sees FY2021 EPS of $7.90-$8.10, versus the consensus of $7.18. Gilead Sciences sees FY2021 revenue of $26-26.3 billion, versus the consensus of $25.12 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Chime to acquire Stride Bank for $590M in cash
- BMO Capital Starts Carter's (CRI) at Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
